Drug samples falling out of favor as pharma sales tool

Share this article:
Drug samples falling out of favor as pharma sales tool
Drug samples falling out of favor as pharma sales tool

Drug samples were once  standard in pharmaceutical sales calls. But a report says that isn't so true now. Cegedim Strategic Data found a 25% dip in industry support for samples bewteen 2007 and 2011—from just under $8.5 billion to about $6 billion.

The drop is part of a shift in the relationship between pharma's traditional methods of promotion—sampling and detailing—and a landscape in which physician behavior is dictated by type of practice, said consultant Richard Vanderveer.

According to  Vanderveer, doctors used to be more inclined to meet with a sales representative, discuss a drug's merits and get samples—but current clinicians, pressed for time, are cutting sales meetings short. He also notes that treatment protocols at larger care organizations may be making samples less relevant.

CSD says sales reps are now 36% less likely to walk into a physician's office with the intent of leaving a sample—unless they are calling on a new doctor with no prescribing history. In those cases, CSD found samples increase the likelihood of a prescription by 81%, compared with a 51% uptake rate among new doctors who didn't get samples.

Vanderveer says the data also show a shift in sales calls themselves. He thinks trained medical liaisons will have a larger role than traditional sales representatives, as doctors will be more likely to welcome them—whether or not the visit includes samples.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.